Vantas Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Post Your Vantas Experience:
Recent Vantas Side Effect Reports
Vantas Side Effects Report #5274703-3
Physician from UNITED STATES reported Vantas side effect on Mar 09, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient was hospitalized.
Vantas Side Effects Report #5290169-1
Vantas side effect was reported by a Physician from UNITED STATES on Mar 27, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: carotid artery occlusion, cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ECOTRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX. Patient was hospitalized.
Physician from UNITED STATES reported Vantas side effect on Mar 09, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient was hospitalized. 
Vantas Side Effects Report #5290169-1
Vantas side effect was reported by a Physician from UNITED STATES on Mar 27, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: carotid artery occlusion, cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ECOTRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX. Patient was hospitalized. View More
View All Vantas FDA Adverse ReportsVantas Side Effects
Go to the top of the page
Vantas Questions
Ask Community about Vantas:
No comments have been provided.
Ask Community about Vantas:
What is Your Question? Ask Community:
Vantas Adverse Effect Reports (FDA)
Health Professional from UNITED STATES reported Vantas side effect on Mar 28, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: carotid artery occlusion, cerebrovascular accident, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ASPIRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX.
Vantas Side Effects Report #5308283-0
Vantas side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ASPIRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX.
Vantas Side Effects Report #5355318-5
Consumer or non-health professional from UNITED STATES reported Vantas side effect on May 23, 2007. Male patient was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: neoplasm malignant. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q.. Patient died on 01/01/2007.
Vantas Side Effects Report #5492055-0
Vantas side effect was reported by a Physician from UNITED STATES on Oct 05, 2007. Male patient, 90 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: shock, vomiting. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient died on 10/04/2007.
Vantas Side Effects Report #5506564-9
Physician from UNITED STATES reported Vantas side effect on Oct 25, 2007. Male patient, 95 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: shock, vomiting. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with HYZAAR, KCL SUPPLEMENT, FOLIC ACID. Patient died on 10/04/2007.
Vantas Side Effects Report #5813955-5
Vantas side effect was reported by a Pharmacist from UNITED STATES on July 09, 2008. Male patient, 83 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis . Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q, IMPLANT. During the same period patient was treated with NORVASC, CALCITRIOL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, NEPHROVITE. Patient was hospitalized.
Vantas Side Effects Report #5844456-6
Physician from UNITED STATES reported Vantas side effect on July 28, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: cellulitis . Vantas dosage: 50 MG, 1 IN 1Y, SUB Q. IMPLANT. During the same period patient was treated with SANCTURA. Patient was hospitalized.
Vantas Side Effects Report #5884183-2
Vantas side effect was reported by a Physician from UNITED STATES on Aug 27, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: implant site cellulitis. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with SANCTURA. Patient was hospitalized.
Vantas Side Effects Report #6033260-4
Health Professional from UNITED STATES reported Vantas side effect on Dec 22, 2008. Male patient, 73 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: dyspnoea, oedema, rash pruritic. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient was hospitalized.
Vantas Side Effects Report #4589719-X
Vantas side effect was reported by a Health Professional from on Feb 14, 2005. Male patient, 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: chest pain , delirium, implant site pain, pain in extremity, posture abnormal. Vantas dosage: 50 MG, 1/YEAR, 0.57IMPLANT. During the same period patient was treated with ALLOPURINOL, ZANTAC, CLINDEX, MEGACE, LIBRAX, PERPHENOZINE, AMITRIPTYLINE, CELEXA. Patient was hospitalized.
Vantas Side Effects Report #4604291-3
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with GLUCOTROL, GLUCOPHAGE, CASEDEX. Patient died on 11/28/2004.
Vantas Side Effects Report #4604294-9
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with NORVASC, TOPROL, GLYBURIDE, ENALAPRIL, FUROSEMIDE, ISOSORBIDE ONCE PER DAY, NITRO PATCH ONCE PER DAY, ASPIRIN. Patient died on 11/29/2004.
Vantas Side Effects Report #4614263-0
Health Professional from reported Vantas side effect on Mar 14, 2005. Male patient, 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: chest pain , delirium, fall , implant site pain. Vantas dosage: 50MG, 1/YEAR, 057IMPLANT. During the same period patient was treated with ALLOPURINOL, ZANTAC, CLINDEX, MEGACE, LIBRAX, PERPHENOZINE, AMITRIPTYLINE, CELEXA.
Vantas Side Effects Report #4616460-7
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: cardiomyopathy , refusal of treatment by patient. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, GLYBURIDE, ENALAPRIL, LASIX, ISOSORBIDE, NITROGLYN, ASPIRIN. Patient died on 11/29/2004.
Vantas Side Effects Report #4616461-9
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: dysuria, oesophageal varices haemorrhage, prostatic specific antigen increased, refusal of treatment by patient. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with GLUCOTROL, METFORMIN, BICALUTAMIDE. Patient died on 11/28/2004.
Vantas Side Effects Report #4604291-3
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with GLUCOTROL, GLUCOPHAGE, CASEDEX. Patient died on 11/28/2004.
Vantas Side Effects Report #4604294-9
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with NORVASC, TOPROL, GLYBURIDE, ENALAPRIL, FUROSEMIDE, ISOSORBIDE ONCE PER DAY, NITRO PATCH ONCE PER DAY, ASPIRIN. Patient died on 11/29/2004.
Vantas Side Effects Report #4698579-8
Vantas side effect was reported by a Physician from on May 27, 2005. Male patient was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: polymyositis. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized.
Vantas Side Effects Report #4712558-3
Physician from UNITED STATES reported Vantas side effect on May 27, 2005. Male patient was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: polymyositis. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized.
Vantas Side Effects Report #4729448-2
Vantas side effect was reported by a Physician from UNITED STATES on July 25, 2005. Male patient was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, pneumonia . Vantas dosage: 50 MG/YEAR, SUBCUTANEOUS. Patient was hospitalized.
Vantas Side Effects Report #4736509-0
Physician from UNITED STATES reported Vantas side effect on July 25, 2005. Male patient was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, pneumonia . Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized.
Vantas Side Effects Report #4748629-5
Vantas side effect was reported by a Physician from UNITED STATES on May 27, 2005. Male patient, 68 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: angioplasty , blood creatine phosphokinase increased, c-reactive protein increased, hypoxia, polymyositis, red blood cell sedimentation rate increased, vital capacity decreased. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with CLOPIDPGREL BISULPHATE, ASPIRIN, ATENOLOL, ENOXAPARIN, FERROUS SULPHATE, PROZAC, FOLIC ACID. Patient was hospitalized. Patient died on 08/09/2005.
Vantas Side Effects Report #4764228-3
Consumer or non-health professional from UNITED STATES reported Vantas side effect on Sept 07, 2005. Female patient was diagnosed with prostate cancer, prostatic specific antigen increased and was treated with Vantas. After drug was administered, patient experienced the following side effects: asthenia, fatigue, feeling abnormal, musculoskeletal stiffness, syncope, vertigo. Vantas dosage: unknown.
Vantas Side Effects Report #4834884-X
Vantas side effect was reported by a Physician from UNITED STATES on Nov 04, 2005. Male patient, 69 years of age, was diagnosed with prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: blood testosterone increased, implant site reaction, prostatic specific antigen increased. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS.
Vantas Side Effects Report #4945414-6
Consumer or non-health professional from UNITED STATES reported Vantas side effect on Mar 07, 2006. Male patient, 81 years of age, weighting 185.0 lb, was diagnosed with disease recurrence, prostate cancer and was treated with Vantas. After drug was administered, patient experienced the following side effects: device migration, failure of implant. Vantas dosage: unknown.
Vantas Side Effects Report #4968958-X
Vantas side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2006. Male patient, 68 years of age, was diagnosed with prostate cancer metastatic and was treated with Vantas. After drug was administered, patient experienced the following side effects: bone pain, convulsion, depression, epistaxis, hot flush, hyperhidrosis, insomnia, muscle twitching, pollakiuria. Vantas dosage: 50 MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with XANAX, HYDROMORPHINE.
Go to the top of the page
Vantas Side Effects Report #5292675-2
Health Professional from UNITED STATES reported Vantas side effect on Mar 28, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: carotid artery occlusion, cerebrovascular accident, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ASPIRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX. Vantas Side Effects Report #5308283-0
Vantas side effect was reported by a Physician from UNITED STATES on Apr 17, 2007. Male patient, 88 years of age, weighting 192.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hypoaesthesia, oedema peripheral. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with ASPIRIN, DIOVAN HCT, CRESTOR, METFORMIN, CASODEX. Vantas Side Effects Report #5355318-5
Consumer or non-health professional from UNITED STATES reported Vantas side effect on May 23, 2007. Male patient was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: neoplasm malignant. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q.. Patient died on 01/01/2007.Vantas Side Effects Report #5492055-0
Vantas side effect was reported by a Physician from UNITED STATES on Oct 05, 2007. Male patient, 90 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: shock, vomiting. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient died on 10/04/2007.Vantas Side Effects Report #5506564-9
Physician from UNITED STATES reported Vantas side effect on Oct 25, 2007. Male patient, 95 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: shock, vomiting. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with HYZAAR, KCL SUPPLEMENT, FOLIC ACID. Patient died on 10/04/2007.Vantas Side Effects Report #5813955-5
Vantas side effect was reported by a Pharmacist from UNITED STATES on July 09, 2008. Male patient, 83 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: blood creatinine increased, dialysis . Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q, IMPLANT. During the same period patient was treated with NORVASC, CALCITRIOL, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, NEPHROVITE. Patient was hospitalized. Vantas Side Effects Report #5844456-6
Physician from UNITED STATES reported Vantas side effect on July 28, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: cellulitis . Vantas dosage: 50 MG, 1 IN 1Y, SUB Q. IMPLANT. During the same period patient was treated with SANCTURA. Patient was hospitalized. Vantas Side Effects Report #5884183-2
Vantas side effect was reported by a Physician from UNITED STATES on Aug 27, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: implant site cellulitis. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. During the same period patient was treated with SANCTURA. Patient was hospitalized. Vantas Side Effects Report #6033260-4
Health Professional from UNITED STATES reported Vantas side effect on Dec 22, 2008. Male patient, 73 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: dyspnoea, oedema, rash pruritic. Vantas dosage: 50 MG, 1 IN 1 Y, SUB Q. IMPLANT. Patient was hospitalized. Vantas Side Effects Report #4589719-X
Vantas side effect was reported by a Health Professional from on Feb 14, 2005. Male patient, 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: chest pain , delirium, implant site pain, pain in extremity, posture abnormal. Vantas dosage: 50 MG, 1/YEAR, 0.57IMPLANT. During the same period patient was treated with ALLOPURINOL, ZANTAC, CLINDEX, MEGACE, LIBRAX, PERPHENOZINE, AMITRIPTYLINE, CELEXA. Patient was hospitalized. Vantas Side Effects Report #4604291-3
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with GLUCOTROL, GLUCOPHAGE, CASEDEX. Patient died on 11/28/2004.Vantas Side Effects Report #4604294-9
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with NORVASC, TOPROL, GLYBURIDE, ENALAPRIL, FUROSEMIDE, ISOSORBIDE ONCE PER DAY, NITRO PATCH ONCE PER DAY, ASPIRIN. Patient died on 11/29/2004.Vantas Side Effects Report #4614263-0
Health Professional from reported Vantas side effect on Mar 14, 2005. Male patient, 84 years of age, weighting 150.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: chest pain , delirium, fall , implant site pain. Vantas dosage: 50MG, 1/YEAR, 057IMPLANT. During the same period patient was treated with ALLOPURINOL, ZANTAC, CLINDEX, MEGACE, LIBRAX, PERPHENOZINE, AMITRIPTYLINE, CELEXA. Vantas Side Effects Report #4616460-7
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: cardiomyopathy , refusal of treatment by patient. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, GLYBURIDE, ENALAPRIL, LASIX, ISOSORBIDE, NITROGLYN, ASPIRIN. Patient died on 11/29/2004.Vantas Side Effects Report #4616461-9
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: dysuria, oesophageal varices haemorrhage, prostatic specific antigen increased, refusal of treatment by patient. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with GLUCOTROL, METFORMIN, BICALUTAMIDE. Patient died on 11/28/2004.Vantas Side Effects Report #4604291-3
Vantas side effect was reported by a Physician from on Dec 01, 2004. Male patient, 78 years of age, weighting 160.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with GLUCOTROL, GLUCOPHAGE, CASEDEX. Patient died on 11/28/2004.Vantas Side Effects Report #4604294-9
Physician from reported Vantas side effect on Dec 01, 2004. Male patient, 85 years of age, weighting 145.0 lb, was diagnosed with prostate cancer
and was treated with Vantas. Vantas dosage: 50 MG, ONCE PER YEAR, IMPLANT 057. During the same period patient was treated with NORVASC, TOPROL, GLYBURIDE, ENALAPRIL, FUROSEMIDE, ISOSORBIDE ONCE PER DAY, NITRO PATCH ONCE PER DAY, ASPIRIN. Patient died on 11/29/2004.Vantas Side Effects Report #4698579-8
Vantas side effect was reported by a Physician from on May 27, 2005. Male patient was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: polymyositis. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized. Vantas Side Effects Report #4712558-3
Physician from UNITED STATES reported Vantas side effect on May 27, 2005. Male patient was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: polymyositis. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized. Vantas Side Effects Report #4729448-2
Vantas side effect was reported by a Physician from UNITED STATES on July 25, 2005. Male patient was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, pneumonia . Vantas dosage: 50 MG/YEAR, SUBCUTANEOUS. Patient was hospitalized. Vantas Side Effects Report #4736509-0
Physician from UNITED STATES reported Vantas side effect on July 25, 2005. Male patient was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, liver disorder, pneumonia . Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Patient was hospitalized. Vantas Side Effects Report #4748629-5
Vantas side effect was reported by a Physician from UNITED STATES on May 27, 2005. Male patient, 68 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: angioplasty , blood creatine phosphokinase increased, c-reactive protein increased, hypoxia, polymyositis, red blood cell sedimentation rate increased, vital capacity decreased. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with CLOPIDPGREL BISULPHATE, ASPIRIN, ATENOLOL, ENOXAPARIN, FERROUS SULPHATE, PROZAC, FOLIC ACID. Patient was hospitalized. Patient died on 08/09/2005.Vantas Side Effects Report #4764228-3
Consumer or non-health professional from UNITED STATES reported Vantas side effect on Sept 07, 2005. Female patient was diagnosed with prostate cancer
, prostatic specific antigen increased and was treated with Vantas. After drug was administered, patient experienced the following side effects: asthenia, fatigue, feeling abnormal, musculoskeletal stiffness, syncope, vertigo. Vantas dosage: unknown. Vantas Side Effects Report #4834884-X
Vantas side effect was reported by a Physician from UNITED STATES on Nov 04, 2005. Male patient, 69 years of age, was diagnosed with prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: blood testosterone increased, implant site reaction, prostatic specific antigen increased. Vantas dosage: 50MG/YEAR, SUBCUTANEOUS. Vantas Side Effects Report #4945414-6
Consumer or non-health professional from UNITED STATES reported Vantas side effect on Mar 07, 2006. Male patient, 81 years of age, weighting 185.0 lb, was diagnosed with disease recurrence, prostate cancer
and was treated with Vantas. After drug was administered, patient experienced the following side effects: device migration, failure of implant. Vantas dosage: unknown. Vantas Side Effects Report #4968958-X
Vantas side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2006. Male patient, 68 years of age, was diagnosed with prostate cancer metastatic and was treated with Vantas. After drug was administered, patient experienced the following side effects: bone pain, convulsion, depression
, epistaxis, hot flush, hyperhidrosis, insomnia, muscle twitching, pollakiuria. Vantas dosage: 50 MG/YEAR, SUBCUTANEOUS. During the same period patient was treated with XANAX, HYDROMORPHINE.
100%